Since 18 of December 2019 conferences.iaea.org uses Nucleus credentials. Visit our help pages for information on how to Register and Sign-in using Nucleus.

Dosimetric optimization of BATD-3D interstitial prostate treatments with 60Co and Multi-image technique

21 Jun 2017, 10:55
5m
Poster New Technologies in Radiation Oncology/Radiotherapy Wednesday morning - Poster Presentations - Screen5

Speaker

Gustavo Sarria Bardales (ONCOSALUD - RED AUNA)

Description

INTRODUCTION: It is presented an efficient and quick method to dosimetric optimization using multi-imaging technique for intersticial prostate cancer HDR brachytherapy (BATD-3D) with 60Co Source- BEBIG. MATERIALS AND METHODS: Establish an optimization process for interstitial needle placement, target volume contour, Organs at risk contour, and treatment planning with the use of different image thechniques (MRI, CT and US) that optimize application time, planning time, and treatment total time. Also it is done dosimetric planification evaluation using different index such as COIN, Paddick Index (PI), conformity/gradient Index (CGI). RESULTS: In table 1 it is seen that dosimetrical values obtained for each organ at risk, achieving constraints for each case. In Table 2 it is also shown quality index to CTV coverage, observing a COINprom=0.738 and stablish the use of the Paddick PIprom=0.757 and accordance/gradient Index ICGprom=78.7%. This way we could see to parameters to quality control for a correct treatment placement. CONCLUSIONS: The correct use of Multi – Imaging optimize the different procedures in the application of interstitial HDR Prostate Brachytherapy (Fig. 1), as well using quality index such as (COIN, PI and ICG) in order to assure a correct treatment dosimetry. Organs at risk dosimetry needs to be in a narrow relation with CTV quality index, achieving the constraints for prostate volumetric treatments in our centre: • Rectum: D0.1cc≤80%, D1cc≤70% y D0.1cc≤60% • Bladder: D0.1cc<90%, D1cc≤60% y D0.1cc≤50% • Urethra: D0.1cc≤120%, D1cc≤70% y D0.1cc≤10%
Institution ONCOSALUD- AUNA
Country PERÚ

Primary author

Anthony Paredes Vargas (ONCOSALUD - RED AUNA)

Co-authors

Bertha GARCIA (RED AUNA - CLINICA DELGADO) David Antonio Martinez Perez (ONCOSALUD) Gustavo Sarria Bardales (ONCOSALUD - RED AUNA) Luis Pinillos Ashton (ONCOSALUD - RED AUNA)

Presentation materials